Science and Technology Innovation Program

PEN 17 - A Hard Pill to Swallow

By
William B. Schultz and Lisa Barclay

WASHINGTON - Historically, the regulation of dietary supplements has been a significant challenge for the U.S. Food and Drug Administration (FDA), and the fact that some of these products are now being manufactured using nanotechnology creates an additional layer of complexity. This new report asks the question: Is FDA equipped to meet the emerging regulatory challenge of dietary supplements that use engineered nanomaterials? The short answer is no.
 

Upcoming Events

Experts & Staff

  • David Rejeski // Director, Science and Technology Innovation Program; Interim Director, Commons Lab
  • Todd Kuiken, Ph.D. // Senior Program Associate, Science and Technology Innovation Program
  • Aaron Lovell // Writer/Editor/Program Manager, Science and Technology Innovation Program
  • Eleonore Pauwels // Program Associate/Researcher, Science and Technology Innovation Program
  • Anne Bowser // Researcher, Data Science and Visualization, Science and Technology Innovation Program
  • Elizabeth Tyson // New Projects/Technology Scout, Science and Technology Innovation Program
  • Sharon Weinberger // Global Fellow
  • Piers Millett // Global Fellow
  • Mark Schaefer // Global Fellow